Competitive environment of pharmaceutical market analyzed in Kazakhstan

Results of the analysis showed some problems in the markets of pharmaceutical and medical industries impacting the competition development.
Thus, the legislation of Kazakhstan has no definitions and distinct criteria of determination of interchangeability of medicines; impact of some cases of incorrect interaction between the medical community and pharmaceutical companies on development of competition at the pharmaceutical market, Prime Minister's website reported.
Within the framework of the analysis, the Agency questioned about 700 pharmacies and detected a barrier to entry the market of retail sale of medicines.
Upon the results of the analysis, the Agency will submit proposals on addressing the detected issues and elimination of barriers to the Government of Kazakhstan and authorized agencies - Ministries of Healthcare and Industry and New Technologies.